Post by Valeur Consulting

💡Turning Doctor Insight into Positive Impact: AusDoc, Valeur Consulting and Bayer The pharmaceutical industry is clear in its intent to be patient and doctor focused. The more important question is how that intent is experienced by doctors in practice. That question sits at the heart of The Uncomfortable Truth, a joint Australian Doctor Group and Valeur Consulting study, which we are sharing with Bayer. Drawing on direct engagement with Australian doctors, the research surfaces realities across workforce pressures, evolving career pathways, technology adoption and the way pharma relationships are perceived on the ground. This work is not about critique. It is about insight. For pharmaceutical companies, understanding where value is genuinely created, where engagement falls short, and where trust can be strengthened is critical to building relevant, future-ready partnerships. 🤝 AusDoc provides unfiltered access to the medical profession. Valeur brings strategic interpretation of that insight. Together, we help organisations move from intent to impact. We commend Bayer for engaging with this work and invite others across the industry to do the same. If we are serious about supporting doctors and patients, the first step is listening. 👂 #DoctorEngagement #TrustInHealthcare #HealthcareInsights #TeamBayer Josh Willis Alicia Melville Clifford Fram Suzy Lucas Donna Collett Caroline Guerbet Bryn McGeever Jason Wegrzyn